Refine Your Results

Click below to filter your search results

"Last 6 Months"Undo
"Medications or Drugs"Undo
"Pelvic support problems or Incontinence"Undo

Search Results

Return to List
Results 1–1 of 1
Title Date
1.

OnabotulinumtoxinA and the Bladder

Number 604

ABSTRACT: In January 2013, the U.S. Food and Drug Administration approved the use of onabotulinumtoxinA (also known as Botox A) for the treatment of overactive bladder, thus providing another treatment option for women. Symptoms of overactive bladder have been shown to significantly improve after ...

June 2014

PDF Format